サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439971

経頭蓋磁気刺激（TMS）- 世界市場の考察、競合情勢、市場予測（2030年）

Transcranial Magnetic Stimulator - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
経頭蓋磁気刺激（TMS）- 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界経頭蓋磁気刺激（TMS）の市場規模は、2023年に11億3,461万米ドル、2030年までに19億1,705万米ドルに達し、2024年～2030年の予測期間にCAGRで9.19％の成長が見込まれます。経頭蓋磁気刺激（TMS）の需要は主に、双極性障害、強迫性障害などの精神疾患の併存症例の急増による、アルツハイマー病やパーキンソン病などのさまざまな神経疾患の患者の増加、精神衛生に関する意識の高まり、喫煙者の増加、非侵襲的治療法への選好の高まり、製品開発における技術革新などによって促進されており、これらが2024年～2030年の予測期間における経頭蓋磁気刺激（TMS）市場全体の成長に寄与します。

経頭蓋磁気刺激（TMS）の市場力学

うつ病、強迫性障害などの精神疾患の継続的な増加が経頭蓋磁気刺激（TMS）市場の成長を促進しています。2022年に世界保健機関（WHO）が発表したデータによると、2019年に全世界で約9億7,000万人、つまり8人に1人が精神障害を抱えて生活していました。この資料はさらに、5,800万人の子供と青少年を含む3億100万人が罹患する不安を伴う不安障害とうつ病性障害が、2019年に世界でもっとも一般的な精神障害であったと述べています。

上記の資料によれば、2019年、世界人口の3.8％を占める約2億8,000万人（2,300万人の子供と青少年を含む）がうつ病を患っていました。

上記の資料はさらに、2019年に全世界で4,000万人が双極性障害を経験し、2019年に子供や青少年を含む4,000万人が反社会的行為障害を抱えて生活していたと述べています。

経頭蓋磁気刺激（TMS）市場に好影響を与える可能性のある複数の神経疾患の有病率は伸びています。WHO（2022）によると、2019年に全世界で約850万人がパーキンソン病（PD）に罹患しており、同じ資料によると、PDは580万の障害調整生存年につながっています。パーキンソン病やアルツハイマー病などの神経疾患の患者は、TMS療法から恩恵を受けることができます。

しかし、TMS療法に伴う副作用やその他の代替の刺激療法の存在が、経頭蓋磁気刺激（TMS）市場の成長を抑制する可能性があります。

経頭蓋磁気刺激（TMS）市場のセグメント分析

経頭蓋磁気刺激（TMS）市場のタイプセグメントでは、深部経頭蓋磁気刺激（dTMS）カテゴリが2023年に大きな収益シェアを獲得すると予測されています。これは、深部経頭蓋磁気刺激装置（dTMS）の神経精神疾患の効果的な治療に関連する利点と用途によるものと考えられます。

脳のより深く、より広い領域を刺激することで、深部TMSは脳震盪、PTSD、うつ病、強迫性障害、不安、中毒などを含む多くの精神的健康状態に非侵襲的で革新的かつ効果的な治療を提供します。

dTMSではHコイルを直接活性化させることで、磁場の強さを大幅に増加させることなく、磁気パルスが脳の特定部位を標的とすることができ、治療による副作用や悪影響を最小限に抑えることができます。

さまざまな治療を試みても症状が改善しないMDD患者は、抗うつ薬よりもリスクがなく良好な結果をもたらす深部TMSによって緩和される可能性があります。

抗うつ薬の使用に伴う吐き気、体重増加、不妊、眠気、慢性下痢、口渇、発疹、記憶喪失などの副作用は、深部TMSの利用によって解消されます。

したがって、上記の要因から、深部経頭蓋磁気刺激（dTMS）カテゴリは大きな成長を記録すると予測され、それによって予測期間の経頭蓋磁気刺激（TMS）市場全体の成長を促進します。

北米が経頭蓋磁気刺激（TMS）市場全体を独占すると予測されます。

すべての地域の中で、北米が2023年に経頭蓋磁気刺激（TMS）市場で最大のシェアを占めると推定されています。神経疾患の有病率の上昇、精神疾患の患者の増加、高い可処分所得、精巧な医療インフラ、主要企業のプレゼンス、製品開発活動の増加、その他の重大な成長要因のおかげで、経頭蓋磁気刺激（TMS）市場は予測期間の2022年～2028年にこの地域で活況を示すことが見込まれます。

当レポートでは、世界の経頭蓋磁気刺激（TMS）市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 経頭蓋磁気刺激（TMS）市場レポートのイントロダクション

第2章 経頭蓋磁気刺激（TMS）市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 経頭蓋磁気刺激（TMS）市場の主な要因の分析

  • 経頭蓋磁気刺激（TMS）市場の促進要因
  • 経頭蓋磁気刺激（TMS）市場の抑制要因と課題
  • 経頭蓋磁気刺激（TMS）市場の機会

第5章 経頭蓋磁気刺激（TMS）市場のポーターのファイブフォース分析

第6章 経頭蓋磁気刺激（TMS）市場レイアウト

  • タイプ別
    • 深部経頭蓋磁気刺激装置（dTMS）
    • 反復経頭蓋磁気刺激装置（rTMS）
    • その他
  • 用途別
    • アルツハイマー病
    • 強迫性障害（OCD）
    • 双極性うつ病
  • 年齢層別
    • 成人
    • 子供
  • 地域
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第7章 経頭蓋磁気刺激（TMS）市場の企業と製品のプロファイル

  • BrainsWay
  • Nexstim
  • Magstim
  • Neuronetics
  • Salience
  • MagVenture, Inc.
  • Axilum Robotics
  • Brainbox Ltd.
  • EB Neuro S.p.A.
  • eNeura Inc.
  • Neurosoft
  • MAG & More GmbH
  • Soterix Medical Inc.
  • Magnus Medical
  • NEUROPREX INC.

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Transcranial Magnetic Stimulation (TMS) Market in Global (2021-2030)
  • Table 3: Transcranial Magnetic Stimulation (TMS) Market in Global by Type (2021-2030)
  • Table 4: Transcranial Magnetic Stimulation (TMS) Market in Global by Application (2021-2030)
  • Table 5: Transcranial Magnetic Stimulation (TMS) Market in Global by Age Group (2021-2030)
  • Table 6: Transcranial Magnetic Stimulation (TMS) Market in Global by Geography (2021-2030)
  • Table 7: Transcranial Magnetic Stimulation (TMS) Market in North America (2021-2030)
  • Table 8: Transcranial Magnetic Stimulation (TMS) Market in North America by Country (2021-2030)
  • Table 9: Transcranial Magnetic Stimulation (TMS) Market in the US (2021-2030)
  • Table 10: Transcranial Magnetic Stimulation (TMS) Market in Canada (2021-2030)
  • Table 11: Transcranial Magnetic Stimulation (TMS) Market in Mexico (2021-2030)
  • Table 12: Transcranial Magnetic Stimulation (TMS) Market in Europe (2021-2030)
  • Table 13: Transcranial Magnetic Stimulation (TMS) Market in Europe by Country (2021-2030)
  • Table 14: Transcranial Magnetic Stimulation (TMS) Market in France (2021-2030)
  • Table 15: Transcranial Magnetic Stimulation (TMS) Market in Germany (2021-2030)
  • Table 16: Transcranial Magnetic Stimulation (TMS) Market in the United Kingdom (2021-2030)
  • Table 17: Transcranial Magnetic Stimulation (TMS) Market in Italy (2021-2030)
  • Table 18: Transcranial Magnetic Stimulation (TMS) Market in Spain (2021-2030)
  • Table 19: Transcranial Magnetic Stimulation (TMS) Market in the Rest of Europe (2021-2030)
  • Table 20: Transcranial Magnetic Stimulation (TMS) Market in Asia-Pacific (2021-2030)
  • Table 21: Transcranial Magnetic Stimulation (TMS) Market in Asia-Pacific by Country (2021-2030)
  • Table 22: Transcranial Magnetic Stimulation (TMS) Market in China (2021-2030)
  • Table 23: Transcranial Magnetic Stimulation (TMS) Market in Japan (2021-2030)
  • Table 24: Transcranial Magnetic Stimulation (TMS) Market in India (2021-2030)
  • Table 25: Transcranial Magnetic Stimulation (TMS) Market in Australia (2021-2030)
  • Table 26: Transcranial Magnetic Stimulation (TMS) Market in South Korea (2021-2030)
  • Table 27: Transcranial Magnetic Stimulation (TMS) Market in Rest of Asia-Pacific (2021-2030)
  • Table 28: Transcranial Magnetic Stimulation (TMS) Market in the Rest of the World (2021-2030)
  • Table 29: Transcranial Magnetic Stimulation (TMS) Market in RoW by Region (2021-2030)
  • Table 30: Transcranial Magnetic Stimulation (TMS) Market in the Middle East (2021-2030)
  • Table 31: Transcranial Magnetic Stimulation (TMS) Market in Africa (2021-2030)
  • Table 32: Transcranial Magnetic Stimulation (TMS) Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Transcranial Magnetic Stimulation (TMS) Market in Global (2021-2030)
  • Figure 3: Transcranial Magnetic Stimulation (TMS) Market in Global by Type (2021-2030)
  • Figure 4: Transcranial Magnetic Stimulation (TMS) Market in Global by Application (2021-2030)
  • Figure 5: Transcranial Magnetic Stimulation (TMS) Market in Global by Age Group (2021-2030)
  • Figure 6: Transcranial Magnetic Stimulation (TMS) Market in Global by Geography (2021-2030)
  • Figure 7: Transcranial Magnetic Stimulation (TMS) Market in North America (2021-2030)
  • Figure 8: Transcranial Magnetic Stimulation (TMS) Market in North America by Country (2021-2030)
  • Figure 9: Transcranial Magnetic Stimulation (TMS) Market in the US (2021-2030)
  • Figure 10: Transcranial Magnetic Stimulation (TMS) Market in Canada (2021-2030)
  • Figure 11: Transcranial Magnetic Stimulation (TMS) Market in Mexico (2021-2030)
  • Figure 12: Transcranial Magnetic Stimulation (TMS) Market in Europe (2021-2030)
  • Figure 13: Transcranial Magnetic Stimulation (TMS) Market in Europe by Country (2021-2030)
  • Figure 14: Transcranial Magnetic Stimulation (TMS) Market in France (2021-2030)
  • Figure 15: Transcranial Magnetic Stimulation (TMS) Market in Germany (2021-2030)
  • Figure 16: Transcranial Magnetic Stimulation (TMS) Market in the United Kingdom (2021-2030)
  • Figure 17: Transcranial Magnetic Stimulation (TMS) Market in Italy (2021-2030)
  • Figure 18: Transcranial Magnetic Stimulation (TMS) Market in Spain (2021-2030)
  • Figure 19: Transcranial Magnetic Stimulation (TMS) Market in the Rest of Europe (2021-2030)
  • Figure 20: Transcranial Magnetic Stimulation (TMS) Market in Asia-Pacific (2021-2030)
  • Figure 21: Transcranial Magnetic Stimulation (TMS) Market in Asia-Pacific by Country (2021-2030)
  • Figure 22: Transcranial Magnetic Stimulation (TMS) Market in China (2021-2030)
  • Figure 23: Transcranial Magnetic Stimulation (TMS) Market in Japan (2021-2030)
  • Figure 24: Transcranial Magnetic Stimulation (TMS) Market in India (2021-2030)
  • Figure 25: Transcranial Magnetic Stimulation (TMS) Market in Australia (2021-2030)
  • Figure 26: Transcranial Magnetic Stimulation (TMS) Market in South Korea (2021-2030)
  • Figure 27: Transcranial Magnetic Stimulation (TMS) Market in Rest of Asia-Pacific (2021-2030)
  • Figure 28: Transcranial Magnetic Stimulation (TMS) Market in the Rest of the World (2021-2030)
  • Figure 29: Transcranial Magnetic Stimulation (TMS) Market in RoW by Region (2021-2030)
  • Figure 30: Transcranial Magnetic Stimulation (TMS) Market in the Middle East (2021-2030)
  • Figure 31: Transcranial Magnetic Stimulation (TMS) Market in Africa (2021-2030)
  • Figure 32: Transcranial Magnetic Stimulation (TMS) Market in South America (2021-2030)
  • Figure 33: Market Drivers
  • Figure 34: Market Barriers
  • Figure 35: Marker Opportunities
  • Figure 36: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0652

Transcranial Magnetic Stimulation (TMS) Market By Type (Deep Transcranial Magnetic Stimulator (DTMS), Repetitive Transcranial Magnetic Stimulator (RTMS), And Others), Application (Alzheimer's Disease, Obsessive Compulsive Disorder (OCD), Bipolar Depression, And Others), Age Group (Adults And Children), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing cases of depression and rising prevalence of neurological diseases

The global transcranial magnetic stimulation (TMS) market was valued at USD 1,134.61 million in 2023, growing at a CAGR of 9.19% during the forecast period from 2024 to 2030 to reach USD 1,917.05 million by 2030. The demand for transcranial magnetic stimulation (TMS) is primarily being boosted by the increasing patient population suffering from various neurological diseases such as Alzheimer's Disease and Parkinson's disease among others, as the surge in cases of psychiatric comorbidities such as bipolar disorder, obsessive-compulsive disorder, and others, rising awareness regarding mental health, rise in many smokers, growing preference for non-invasive treatment methods, and innovation in product development among others, thereby contributing to the overall growth of the transcranial magnetic stimulation (TMS) market during the forecast period from 2024-2030.

Transcranial Magnetic Stimulation (TMS) Market Dynamics:

The continuous rise in cases of psychiatric comorbidities such as depression, obsessive-compulsive disorder, and others is driving the growth of the transcranial magnetic stimulation (TMS) market. As per the data published by World Health Organization (WHO) in 2022, worldwide around 970 million people which makes 1 in every 8 people were living with a mental disorder in 2019. The source further stated that anxiety and depressive disorders with anxiety affecting 301 million people including 58 million children and adolescents were the most common mental disorders in 2019 globally.

As per the above-mentioned source worldwide around 280 million people making up 3.8% of the global population including 23 million children and adolescents were suffering from depression in 2019.

The source mentioned above further stated that worldwide 40 million people experienced bipolar disorder in 2019 and 40 million people, including children and adolescents, were living with conduct-dissocial disorder in 2019.

The prevalence of several neurological disorders is on the rise which can have a positive impact on the transcranial magnetic stimulation (TMS) market. According to WHO 2022, worldwide around 8.5 million people had Parkinson's disease (PD) in 2019 and as per the same source, PD lead to 5.8 million disability-adjusted life years. Patients suffering from neurological disorders such as Parkinson's, Alzheimer's disease, and others can get benefit from TMS therapy.

However, side effects associated with TMS therapy and the presence of other alternative stimulation therapies may restrict the growth of the transcranial magnetic stimulation (TMS) market.

Transcranial Magnetic Stimulation (TMS) Market Segment Analysis:

Transcranial Magnetic Stimulation (TMS) Market by Type (Deep Transcranial Magnetic Stimulator (dTMS), Repetitive Transcranial Magnetic Stimulator (rTMS), and Others), Application (Alzheimer's Disease, Obsessive Compulsive Disorder (OCD), Bipolar Depression, and Others), Age Group (Adults and Children), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the transcranial magnetic stimulation (TMS) market, the deep transcranial magnetic stimulator (dTMS) category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications associated with deep transcranial magnetic stimulator (dTMS) effective treatment of neuropsychiatric disorders.

By stimulating the deeper, wider regions of the brain, Deep TMS offers non-invasive, innovative, and effective treatment for numerous mental health conditions including concussions, PTSD, depression, OCD, anxiety, addiction, and more.

The direct activation of H-coils in dTMS enables the magnetic pulses to target specific brain regions without significantly increasing the strength of the magnetic field which helps minimize side effects and negative consequences of the treatment.

Patients with MDD whose symptoms have not improved despite trying various treatments may get relief from deep TMS which offers risk-free and favorable results over antidepressants.

The side effects such as nausea, weight gain, infertility, drowsiness, chronic diarrhea, dry mouth, rash, or memory loss associated with the use of antidepressant drugs are eliminated with the utilization of deep TMS.

Therefore, owing to the above-mentioned factors, the deep transcranial magnetic stimulator (dTMS) category is expected to register significant growth, thereby driving the growth of the overall transcranial magnetic stimulation (TMS) market during the forecast period.

North America is expected to dominate the overall Transcranial Magnetic Stimulation (TMS) Market:

Among all the regions, North America is estimated to account for the largest share of the transcranial magnetic stimulation (TMS) market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of neurological disorders, increasing cases of psychiatric disorders, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others, the market for transcranial magnetic stimulation (TMS) is expected to witness prosperity in the region during the forecast period 2022-2028.

According to the National Institute of Mental Health (NIMH) 2022, about 52.9 million people which stands for 21% of the population experienced mental illness in 2020 in the United States. As per the same source 14.2 million people experienced serious mental illness in the United States in 2020.

The above-mentioned source further stated that around 21.0 million adults had at least one major depressive episode in 2020 in the United States.

Another factor contributing to the growth of the TMS market is the continued rise in the number of individuals involved in smoking. For instance, as per the Centers for Disease Control and Prevention 2022, approximately 40 million people smoke cigarettes in the US. As per the same source, every day nearly 1,600 US youth aged 18 years or younger smoke their first cigarette.

Coupled with the factors mentioned above, the increasing interest of product manufacturers in the region also helps in boosting regional product demand. For instance, in August 2020, BrainsWay Ltd., a global leader in the advanced non-invasive treatment of brain disorders, announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the Company's deep transcranial magnetic stimulation (Deep TMS) system for its use as an aid in short-term smoking cessation in adults.

Such measures help in gaining the market share for the manufacturers as well as benefit end users in terms of better product pricing from the competition standpoint, thereby driving the North America transcranial magnetic stimulation (TMS) market forward during the forecast period.

Transcranial Magnetic Stimulation (TMS) Market Key Players:

Some of the key market players operating in the transcranial magnetic stimulation (TMS) market include BrainsWay, Nexstim, Magstim, Neuronetics, Salience, MagVenture, Inc., Axilum Robotics, Brainbox Ltd., EB Neuro S.p.A., eNeura Inc., Neurosoft, MAG & More GmbH, Soterix Medical Inc., Magnus Medical, NEUROPREX INC., and others.

Recent Developmental Activities in the Transcranial Magnetic Stimulation (TMS) Market:

In January 2023, Magstim, a global leader in neuroscience research and transcranial magnetic stimulation (TMS) solutions for mental health, announced that it has received US FDA clearance for its Horizon 3.0 (with or without StimGuide+) and E-z Cool Coil to treat adult patients diagnosed with obsessive compulsive disorder (OCD) as well as major depressive disorder (MDD).

In March 2020, Neuronetics, Inc., a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced that the US Food and Drug Administration (FDA) has recently granted Breakthrough Device Designation for the Company's NeuroStar Advanced Therapy System for the treatment of bipolar depression.

Key Takeaways from the Transcranial Magnetic Stimulation (TMS) Market Report Study

Market size analysis for current transcranial magnetic stimulation (TMS) market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the transcranial magnetic stimulation (TMS) market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global transcranial magnetic stimulation (TMS) market.

Various opportunities available for the other competitor in the transcranial magnetic stimulation (TMS) market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current transcranial magnetic stimulation (TMS) market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for transcranial magnetic stimulation (TMS) market growth in the coming future?

Target Audience who can be benefited from this Transcranial Magnetic Stimulation (TMS) Market Report Study

Transcranial Magnetic Stimulation (TMS) products providers

Research organizations and consulting companies

Transcranial Magnetic Stimulation (TMS) -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in transcranial magnetic stimulation (TMS)

Various End-users who want to know more about the transcranial magnetic stimulation (TMS) market and the latest technological developments in the transcranial magnetic stimulation (TMS) market.

Frequently Asked Questions for the Transcranial Magnetic Stimulation (TMS) Market:

1. What is meant by transcranial magnetic stimulation (TMS)?

Transcranial magnetic stimulation (TMS) which involves the application of powerful magnetic fields to particular areas of the brain is safe, non-invasive, and powerful technique indicated for the treatment of various psychiatric and neurological disorders.

2. What is the market for global transcranial magnetic stimulation (TMS)?

The global transcranial magnetic stimulation (TMS) market was valued at USD 1,134.61 million in 2023, growing at a CAGR of 9.19% during the forecast period from 2024 to 2030 to reach USD 1,917.05 million by 2030.

3. What are the drivers for the global transcranial magnetic stimulation (TMS) market?

The demand for transcranial magnetic stimulation (TMS) is primarily being boosted by the increasing patient population suffering from various neurological diseases such as Alzheimer's Disease and Parkinson's disease among others, as the surge in cases of psychiatric comorbidities such as bipolar disorder, obsessive-compulsive disorder, and others, rising awareness regarding mental health, rise in several smokers, and others, thereby contributing to the overall growth of the transcranial magnetic stimulation (TMS) market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Transcranial Magnetic Stimulation (TMS) market?

Some of the key market players operating in the transcranial magnetic stimulation market include BrainsWay, Nexstim, Magstim, Neuronetics, Salience, MagVenture, Inc., Axilum Robotics, Brainbox Ltd., EB Neuro S.p.A., eNeura Inc., Neurosoft, MAG & More GmbH, Soterix Medical Inc., Magnus Medical, NEUROPREX INC., and others.

5. Which region has the highest share in the transcranial magnetic stimulation (TMS) market?

North America is expected to dominate the overall transcranial magnetic stimulation (TMS) market during the forecast period from 2024-2030. Owing to the factors such as the rising prevalence of neurological disorders, increasing cases of psychiatric disorders, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new products, and high awareness among others, the North America transcranial magnetic stimulation (TMS) market is expected to grow in coming years.

Table of Contents

1.Transcranial Magnetic Stimulation (TMS) Market Report Introduction

2. Transcranial Magnetic Stimulation (TMS) Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Transcranial Magnetic Stimulation (TMS) Market Key Factors Analysis

  • 4.1. Transcranial Magnetic Stimulation (TMS) Market Drivers
    • 4.1.1. Increasing prevalence of neurological disorders
    • 4.1.2. Surge in cases of psychiatric comorbidities such as depression, obsessive-compulsive disorder, and others
    • 4.1.3. Growing preference for non-invasive treatment options
  • 4.2. Transcranial Magnetic Stimulation (TMS) Market Restraints and Challenges
    • 4.2.1. Side effects associated with TMS therapy
    • 4.2.2. Presence of other alternative stimulation therapies
  • 4.3. Transcranial Magnetic Stimulation (TMS) Market Opportunities
    • 4.3.1. Need to develop well-standardized protocols for TMS
    • 4.3.2. Personalization of TMS therapy

5. Transcranial Magnetic Stimulation (TMS) Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Transcranial Magnetic Stimulation (TMS) Market Layout

  • 6.1. By Type
    • 6.1.1. Deep Transcranial Magnetic Stimulator (dTMS)
    • 6.1.2. Repetitive Transcranial Magnetic Stimulator (rTMS)
    • 6.1.3. Others
  • 6.2. By Application
    • 6.2.1. Alzheimer's disease
    • 6.2.2. Obsessive-compulsive disorder (OCD)
    • 6.2.3. Bipolar Depression
    • 6.2.4. Others
  • 6.3. By Age Group
    • 6.3.1. Adults
    • 6.3.2. Children
  • 6.4. By Geography
    • 6.4.1. North America
      • 6.4.1.1. United States Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
    • 6.4.2. Europe
      • 6.4.2.1. France Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific
      • 6.4.3.1. China Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.3. India Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW)
      • 6.4.4.1. Middle East Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)

7. Transcranial Magnetic Stimulation (TMS) Market Company and Product Profiles

  • 7.1. BrainsWay
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Nexstim
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Magstim
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Neuronetics
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Salience
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. MagVenture, Inc.
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Axilum Robotics
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Brainbox Ltd.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. EB Neuro S.p.A.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. eNeura Inc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Neurosoft
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. MAG & More GmbH
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Soterix Medical Inc.
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Magnus Medical
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. NEUROPREX INC.
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us